^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    MEDI-3617

    i
    Other names: MEDI-3617
    Associations
    News
    Trials
    Company:
    AstraZeneca
    Drug class:
    Angiopoietin 2 inhibitor, TIE inhibitor
    Related drugs:
    Associations
    News
    Trials